FORTEO [teriparatide (rDNA origin) injection] can be used to treat postmenopausal women with osteoporosis at high risk for fracture, to increase bone mass in men with osteoporosis, and for patients with osteoporosis associated with sustained glucocorticoi
Sign up for information and support from FORTEO Connect. Fill out this form to enroll in the osteoporosis bone loss support program and patient services.
FORTEO is indicated for postmenopausal women with osteoporosis at risk for fracture, to increase bone mass in men with osteoporosis at risk for fracture, and for patients with osteoporosis associated with sustained glucocorticoid therapy.
FORTEO is indicated for postmenopausal women with osteoporosis at risk for fracture, to increase bone mass in men with osteoporosis at risk for fracture, and for patients with osteoporosis associated with sustained glucocorticoid therapy.
FORTEO is indicated for postmenopausal women with osteoporosis at risk for fracture, to increase bone mass in men with osteoporosis at risk for fracture, and for patients with osteoporosis associated with sustained glucocorticoid therapy.
The cause of your spine fracture could be osteoporosis. To reduce your risk for fracture due to osteoporosis, it may be time to find out about a treatment that can help.